Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Sermorelin Protocol Comparison — Dose Schedules and Expected Outcomes

Conservative Initiation 200mcg nightly 5 nights/week 20–35ng/mL from baseline First-time peptide users, baseline IGF-1 >150ng/mL, or age >55 with unknown GH reserve Minimises side effects, allows receptor sensitivity assessment, lower cost during trial phase.

This comparison does not assign a generated winner or score.

  • Conservative Initiation
  • 200mcg nightly
  • 5 nights/week
  • 20–35ng/mL from baseline
  • First-time peptide users, baseline IGF-1 >150ng/mL, or age >55 with unknown GH reserve
  • Minimises side effects, allows receptor sensitivity assessment, lower cost during trial phase. Best for risk-averse patients
  • Standard Maintenance
  • 300mcg nightly
  • 6–7 nights/week
  • 40–65ng/mL from baseline
  • Most adult patients aged 35–55 with baseline IGF-1 120–180ng/mL after successful 8-week initiation
  • Achieves target IGF-1 restoration with manageable injection burden and cost. Most physicians default to this after dose-finding phase
  • Aggressive Optimisation
  • 500mcg nightly
  • 7 nights/week
  • 60–90ng/mL from baseline
  • Severe GH deficiency (baseline IGF-1 <120ng/mL), competitive athletes in off-season, or body recomposition protocols under medical supervision
  • Maximum receptor stimulation before diminishing returns, higher cost and injection site reaction risk. Reserve for patients who tolerate 300mcg without issues
More references

Related material